Health News

Experimental 'Peanut Patch' Desensitizes Toddlers with Peanut Allergies in Late-Stage Trial, Offering Hope for New Treatment Option

A recent trial involving more than 200 children between the ages of 1 and 3 who have peanut allergies demonstrated that an experimental patch named Viaskin could help desensitize toddlers to peanuts. The patch is worn around 22 hours a day for a year and contains a small dose of peanut protein that is absorbed through the skin and helps suppress the allergic response. 

The Viaskin patch offers a non-oral option for children under 4 with peanut allergies, and its goal is to build a protective layer for children so that accidental peanut exposure does not lead to severe reactions. The trial showed that 67% of toddlers could tolerate the equivalent of one to four peanuts after a year of wearing the patch. Moreover, the trial found that the nature of the allergic reaction changed, with a decrease in severe reactions. DBV Technologies plans to submit Viaskin for FDA approval once it gathers more safety data about the patch in toddlers and children.

Other News

Subscribe To Our Newsletter

Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.

Subscribe Now   

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks